C07D 277/50
Nitrogen atoms bound to hetero atoms
C07D277/50 (Nitrogen atoms bound to hetero atoms) appears on 197 US grants and 186 published applications in this corpus.
Search patents in C07D- Granted patents
- 197
- Published applications
- 186
- Assignees
- 164
- Inventors
- 757
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 5 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 6 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 6 | 0 |
| 2002 | 3 | 3 |
| 2003 | 3 | 11 |
| 2004 | 4 | 10 |
| 2005 | 4 | 5 |
| 2006 | 10 | 8 |
| 2007 | 1 | 7 |
| 2008 | 3 | 4 |
| 2009 | 8 | 5 |
| 2010 | 5 | 10 |
| 2011 | 6 | 8 |
| 2012 | 11 | 4 |
| 2013 | 7 | 10 |
| 2014 | 6 | 6 |
| 2015 | 7 | 7 |
| 2016 | 4 | 9 |
| 2017 | 7 | 11 |
| 2018 | 3 | 10 |
| 2019 | 16 | 11 |
| 2020 | 8 | 11 |
| 2021 | 3 | 5 |
| 2022 | 6 | 4 |
| 2023 | 4 | 12 |
| 2024 | 2 | 8 |
| 2025 | 8 | 5 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- WDR5-MYC inhibitors10 Feb 2026US 12,545,649 B2Vanderbilt University
- Aminothiazole compounds as inhibitors of CTPS123 Dec 2025US 12,503,466 B2Step Pharma S.A.S.
- Sulphonyl urea derivatives as NLRP3 inflammasome modulators4 Nov 2025US 12,459,925 B2NodThera Limited
- CTPS1 inhibitors and uses thereof17 Jun 2025US 12,331,046 B2Nimbus Clotho, Inc.
- Compound as ctps1 inhibitor6 Aug 2026US 2026/0226026 A1Hangzhou Innogate Pharma Co., Ltd.
- N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels background6 Aug 2026US 2026/0226040 A1Merck Sharp & Dohme Corp.
- Compounds21 Aug 2025US 2025/0263407 A1Step Pharma S.A.A.
- Transcription Factor Brn2 Inhibitory Compounds for Use as Therapeutics26 Jun 2025US 2025/0205204 A1
- Method for forming aminothiazole derivatives with super-paramagnetic nanoparticle catalyst26 Jun 2025US 2025/0206709 A1Imam Abdulrahman Bin Faisal University
Most cited
By later US patents
- Cephem derivative162US 4,278,793 AHoechst Aktiengesellschaft · 1981
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008
- Aryl carbonyl derivatives as therapeutic agents123US 7,541,373 B2Novo Nordisk A/S · 2009
- Aryl aniline β2 adrenergic receptor agonists62US 6,670,376 B1Theravance, Inc. · 2003
- Novel heterocyclic compounds60US 4,803,277 ANihon Tokushu Noyaku Seizo K. K. · 1989